Author

Anat Bel-Ange

The Neuroendocrine Tumor Unit, European Neuroendocrine Tumor Society Center of Excellence, Division of Internal Medicine, Hadassah Medical Center, Jerusalem 9112102, Israel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Chava Brim· 1 shared Ester Davis· 1 shared Firas Abu AkariD· 1 shared Israel Antman· 1 shared Karine Atlan· 1 shared Merav HechtiD· 1 shared Mohammad Jumaa· 1 shared Ofra Maimon· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chava Brim

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivNov 17, 2023

Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications

Ester Davis, Shani Avniel-Polak, Shahd Abu-Kamel…·Yotam Drier

This study identifies three regulatory subtypes of lung neuroendocrine tumors through ChIP-seq and RNA-seq, revealing distinct transcription factor signatures and therapeutic vulnerabilities.

DOI 10.1073/pnas.2405001121

humanChIP-seq

𝕏 PostBluesky